Summit Securities Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,000
Closed -$256K 1131
2021
Q4
$256K Buy
+3,000
New +$234K 0.01% 537
2016
Q1
Sell
-13
Closed -$19K 171
2015
Q4
$19K Buy
+13
New +$865 0.01% 235

Other funds holding CL

Summit Securities Group's CL Position: Q1 2026 in Review

Summit Securities Group reduced its Colgate-Palmolive (CL) stake by 89% in Q1 2026, selling an estimated $94.7K and leaving 133 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #645.

Summit Securities Group first reported a position in CL in Q2 2013 and has held it in 19 quarters since. The position peaked at $5.27M in Q3 2013. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Summit Securities Group held 133 shares of Colgate-Palmolive worth $11.3K as of Q1 2026.
  • Summit Securities Group sold 1,063 Colgate-Palmolive shares in Q1 2026, an estimated $94.7K.
  • Colgate-Palmolive made up ﹤0.01% of Summit Securities Group's portfolio in Q1 2026, its #645 holding.
  • Summit Securities Group first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 19 quarters since.
  • Summit Securities Group's Colgate-Palmolive position peaked at $5.27M in Q3 2013.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.